Skip to main content
IART
NASDAQ Industrial Applications And Services

Integra LifeSciences Q2 2026: Net Income Swings to $4.5M, Guidance Reaffirmed, but Cincinnati Flood Adds Uncertainty

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$16.24
Mkt Cap
$1.283B
52W Low
$8.7
52W High
$20.49
52W Position info
87% above low
Off High info
21% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

IART sits 87% above its 52-week low of $8.7 on elevated volume (2.4× avg).

Summary

Integra LifeSciences swung to a Q2 profit of $4.5M from a year-ago loss, reaffirmed guidance, but disclosed a flood at its Cincinnati plant that could disrupt operations.


Key Events · Earnings and Guidance · IART

  • Q2 Profit Recovery

    Net income of $4.5M vs. a $484.1M loss in Q2 2025, driven by absence of goodwill impairment and improved gross margin to 52.5%.

  • Revenue Growth

    Total revenue of $418.8M, up 0.8% year-over-year, with Specialty Surgery up 1.7% and Tissue Reconstruction down 1.9%.

  • Full-Year Guidance Reaffirmed

    Management reaffirmed its 2026 adjusted EPS outlook of $2.40–$2.50, signaling confidence despite ongoing tariff and operational challenges.

  • Cincinnati Flood Disruption

    A July 17 flood damaged the Cincinnati manufacturing facility; financial impact is being assessed, but insurance coverage is expected to mitigate losses.


Analysis · IART · Industrial Applications And Services

A sharp turnaround defined Integra LifeSciences' Q2 2026, as net income reached $4.5 million versus a $484 million loss a year ago, helped by the absence of last year's goodwill impairment and stronger gross margins. Revenue edged up to $418.8 million. Confidence in the recovery path was underscored by the reaffirmed full-year outlook. Yet a new risk surfaced: a July 17 flood at the Cincinnati manufacturing facility disrupted operations, and the financial impact remains under assessment. Although insurance is expected to cover much of the damage, near-term uncertainty has been introduced. The filing also revealed a new CEO employment agreement and a separation for a former executive, reflecting continued leadership stabilization.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IART was trading at $16.24 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $8.70 to $20.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IART - Latest Insights

IART
Oct 21, 2026, 1:00 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $12.43
Real-time Price: $13.25 info
Change: +$0.820 (+7%) info
Market Cap: $1.031B info
IART
Oct 21, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $13.25 info
Change: $0 (0%) info
Market Cap: $1.031B info
IART
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $13.25 info
Change: $0 (0%) info
Market Cap: $1.031B info
IART
Oct 19, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.45
Real-time Price: $13.25 info
Change: -$0.200 (-1%) info
Market Cap: $1.031B info
IART
Oct 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $13.25 info
Change: -$0.190 (-1%) info
Market Cap: $1.031B info